Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001490978-24-000089
Filing Date
2024-11-12
Accepted
2024-11-12 07:33:31
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sdgr-20240930.htm   iXBRL 10-Q 1875039
2 EX-31.1 sdgr-20240930x10qex311.htm EX-31.1 9975
3 EX-31.2 sdgr-20240930x10qex312.htm EX-31.2 10005
4 EX-32.1 sdgr-20240930x10qex321.htm EX-32.1 4167
5 EX-32.2 sdgr-20240930x10qex322.htm EX-32.2 4192
  Complete submission text file 0001490978-24-000089.txt   7781474

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20240930.xsd EX-101.SCH 56242
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sdgr-20240930_cal.xml EX-101.CAL 63604
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sdgr-20240930_def.xml EX-101.DEF 312466
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20240930_lab.xml EX-101.LAB 646227
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20240930_pre.xml EX-101.PRE 452107
76 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20240930_htm.xml XML 912909
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39206 | Film No.: 241443332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)